JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

Search

AngioDynamics Inc

Open

SectorHealthcare

12.11 -0.08

Overview

Share price change

24h

Current

Min

11.85

Max

12.29

Key metrics

By Trading Economics

Income

-4.9M

-11M

Sales

-4.4M

76M

EPS

-0.03

Profit margin

-14.401

Employees

675

EBITDA

-1.6M

-1.9M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+59.23% upside

Market Stats

By TradingEconomics

Market Cap

46M

487M

Previous open

12.19

Previous close

12.11

News Sentiment

By Acuity

50%

50%

168 / 371 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

AngioDynamics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

9 Dec 2024, 15:23 UTC

Major Market Movers

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

9 Dec 2024, 15:20 UTC

Major Market Movers

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

Peer Comparison

Price change

AngioDynamics Inc Forecast

Price Target

By TipRanks

59.23% upside

12 Months Forecast

Average 19.33 USD  59.23%

High 24 USD

Low 16 USD

Based on 3 Wall Street analysts offering 12 month price targets forAngioDynamics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

3 ratings

3

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

9 / 9.3Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Very Strong Bearish Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

168 / 371 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.
help-icon Live chat